
1. Rev Soc Bras Med Trop. 2021 Nov 12;54:e0270. doi: 10.1590/0037-8682-0270-2021.
eCollection 2021.

Enhanced rapid commercial DNA extraction kit for the molecular detection of
severe acute respiratory syndrome coronavirus 2: Easy adaptation to current
protocols.

Pessoa-E-Silva R(1), Oliveira PSS(1), Gonçalves SMC(1), Guarines KM(1), Carvalho 
LVDN(1), Correia MAB(1), Rosa MMD(1)(2), Rêgo MJBM(1)(2), Pitta MGDR(1)(2),
Pereira MC(1)(3).

Author information: 
(1)Universidade Federal de Pernambuco, Núcleo de Pesquisa em Inovação Terapêutica
- Suely Galdino, Recife, PE, Brasil.
(2)Universidade Federal de Pernambuco, Departamento de Bioquímica, Recife, PE,
Brasil.
(3)Universidade Federal de Pernambuco, Departamento de Fisiologia e Farmacologia,
Recife, PE, Brasil.

INTRODUCTION: Herein, the authors describe a simple enhancement to a commercial
rapid DNA extraction kit based on simple viral lysis for detecting COVID-19 via
RT-qPCR.
METHODS: After testing several different modifications, the adapted protocol with
the best results in preliminary experiments was statistically evaluated in
comparison with an automated robotic protocol.
RESULTS: Processing and testing of 119 nasopharyngeal samples ultimately yielded 
near-perfect agreement with the automated protocol (κ = 0.981 [95% confidence
interval 0.943-1.000]).
CONCLUSIONS: The low cost and rapidity of the enhanced protocol makes it suitable
for adoption in laboratories diagnosing COVID-19, especially those with high
demand for examinations.

DOI: 10.1590/0037-8682-0270-2021 
PMCID: PMC8582969
PMID: 34787260  [Indexed for MEDLINE]

